Anthocyanins and cholesterol

What 3 graded rows on anthocyanins agree on for cholesterol, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Anthocyanins page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Anthocyanins page, with its PubMed record.

Supplement

Anthocyanins Choose another

3 rows · 3,084 people

They agree: all 3 rows found an improvement.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

The best-graded row, grade B, is a meta-analysis of 2,788 people (2023) and found an improvement.

The rows run from 120 to 2,788 people, published from 2009 to 2023: 1 pooled review and 2 single studies.

3 improved

Grade BBlood lipids (LDL, HDL, triglycerides) · Improved
Meta-analysis, 41 studies · n 2,788 · 2023 · 41 placebo-controlled studies (2,788 participants)
Varied by study · Varied by study
Anthocyanins lowered triglycerides (SMD −0.10) and LDL cholesterol (SMD −0.16) and raised HDL cholesterol (SMD 0.42).
Row on the Anthocyanins page · PubMed 37649528 (opens PubMed)
Grade CPlasma ceramides and lipids in dyslipidemia · Improved
RCT · n 176 · 2021 · Adults with dyslipidaemia (169 completed)
40, 80 or 320 mg/day · 12 weeks
All six ceramide species fell dose-dependently; at 320 mg/day Cer16:0 and Cer24:0 fell versus placebo and cholesterol efflux capacity rose.
Row on the Anthocyanins page · PubMed 33131908 (opens PubMed)
Grade CLDL and HDL cholesterol in dyslipidemia · Improved
RCT · n 120 · 2009 · Adults aged 40–65 with dyslipidaemia
160 mg twice daily (320 mg/day) · 12 weeks
HDL rose 13.7% (vs 2.8% placebo) and LDL fell 13.6% (vs a 0.6% rise with placebo); CETP mass and activity fell.
Row on the Anthocyanins page · PubMed 19640950 (opens PubMed)